Galapagos will begin a phase II trial of the drug with 180 patients in 2014. The companies hope the drug will quickly move to a phase III trial.
More Articles on Gastroenterology:
8 Trends Shaping the Present & Future of Gastroenterology
Dr. Andrew Rhim Receives AGA Digestive Cancer Award, $40k Grant
Boston Scientific to Present Data at Digestive Disease Week
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
